AHGIF (Alternate Health) Research & Development: $0.00 Mil (TTM As of Sep. 2019)


What is Alternate Health Research & Development?

Alternate Health AHGIF -99.00% Research & Development is $0.00 Mil as of Sep. 2019.

Research & Development is the aggregate amount of research and development expenses during the year. Alternate Health's Research & Development for the three months ended in Sep. 2019 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2019 was $0.00 Mil.

Alternate Health  (OTCPK:AHGIF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Alternate Health Research & Development Related Terms

Alternate Health Research & Development Historical Data

* Premium members only.

The historical data trend for Alternate Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alternate Health Research & Development Chart

Alternate Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18
Research & Development
0.00 0.00 0.00 0.40 0.36

Alternate Health Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Alternate Health Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Alternate Health (AHGIF) has a Research & Development of $0.00 Mil as of Sep. 2019. Research and development expense is the total cost for research and development activities. View historical data on Alternate Health and its competitors.
Is Alternate Health's Research & Development too high?
Alternate Health's current Research & Development is $0.00 Mil.
How does Alternate Health's Research & Development compare to VEEV and CERN?
Alternate Health's Research & Development of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Alternate Health and its competitors. Alternate Health's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alternate Health stock overvalued right now?
Alternate Health (AHGIF) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Alternate Health (AHGIF), the current Research & Development is $0.00 Mil as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alternate Health Business Description

Address 7373 Broadway Street, Suite 307, San Antonio, TX, USA, 78209
Alternate Health Corp is a healthcare company. It uses expertise in technology and data analytics to revolutionize patient care and research in the emerging medical cannabis industry. It offers practice management and controlled substance management software, blood analysis and toxicology labs, clinical research, continuing education programs, nutraceutical products, and security and control services to the medical cannabis industry.